Promore Pharma
STOCKHOLM, SE / ACCESSWIRE / November 16, 2021 / Promore Pharma (STO:PROMO) (FRA:8T0)
Promore Pharma AB (publ) today announced the composition of the Nomination Committee for the Annual General Meeting 2022, which will be held on Tuesday 17 May 2022. The Nomination Committee shall, according to decided principles for the appointment of the Nomination Committee, consist of the Chairman of the Board and representatives for the three largest shareholders in the company.
The main task of the Nomination Committee is to submit proposals for Chairman of the Board and other members of the Board, remuneration for Board work, the election and remuneration of auditors. The Nomination Committee shall be composed of the Chairman of the Board and members appointed by the three largest shareholders in the company based on ownership of the Company as per the end of September 2021.
Accordingly, the following committee members have been appointed:
- Göran Pettersson, Chairman of the Board
- David Sundin, representing Corespring New Technology AB (former Midroc New Technology)
- Henric Rahm, representing PharmaResearch Co. Ltd
- Hans-Peter Ostler, representing a co-registered group of shareholders, with an ownership equivalent to 8.2% of the company
The Nomination Committee's proposals will be presented in the Notice to the AGM 2022 and on the company web site, www.promorepharma.com. Shareholders desiring to submit comments or proposals to the nomination committee can send them via email to info@promorepharma.com.
For additional information, please contact
Jonas Ekblom, CEO
Phone: [+46] 736 777 540
E-mail: jonas.ekblom@promorepharma.com
Erik Magnusson, CFO
Phone: [+46] 708 565 245
E-mail: erik.magnusson@promorepharma.com
Promore Pharmas Certified Adviser is Erik Penser Bank
Tel: [+46] 8-463 83 00
E-mail: certifiedadviser@penser.se
Promore Pharma in brief
Promore Pharma is a biopharmaceutical company specialized in the development of therapeutic peptides. The company's aim is to develop first-in-category pharmaceuticals for indications with high unmet medical needs, where very few efficacious prescription pharmaceuticals are available. Promore Pharma's two projects are undergoing clinical development and have a very strong safety profile since the products are based on endogeneous substances that are administered locally. The leading project, ensereptide (PXL01), that will be used for prevention of post-surgical scarring, is being prepared for a clinical phase II-trial if the peptide can prevent the formation of unesthetical scars on the skin. Ropocamptide (LL-37) has recently been evaluated in a clinical phase IIb study with positive results in patients with venous leg ulcers (VLUs). The product candidates can also be deployed for other indications, such as preventing unfavorable tissue attachments (adhesions) after different kinds of surgical procedures and treatment of diabetic foot ulcers. The company is listed on Nasdaq First North Growth Market.
SOURCE: Promore Pharma
View source version on accesswire.com:
https://www.accesswire.com/673114/Nomination-Committee-Appointed-for-the-Annual-General-Meeting-2022-in-Promore-Pharma
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion7.1.2026 13:35:00 CET | Press release
Focused on Stability, Regulatory Alignment, and Long-Term Business Growth RAS AL KHAIMAH, UAE / ACCESS Newswire / January 7, 2026 / As businesses face increasing regulatory complexity across borders, RAK ICC offers flexible solutions to simplify expansion and protect assets. RAK ICC offers a straightforward and globally aligned registration of holding companies for high net worth individuals, families and their advisors looking to manage investments, shareholding structures, and regional expansion. With a focus on regulatory compliance and operational efficiency, RAK ICC provides businesses with the tools needed to scale within the UAE and across the region. In an ever-changing global business landscape, RAK ICC allows businesses to operate within the UAE's well-established economic and legal frameworks, ensuring they meet both local and international standards while managing operations effectively. Key Features of RAK ICC's Platform: Streamlined Business Management: RAK ICC makes it e
Datavault AI Announces Experiential Marketing Collaboration with New York’s Fifth Avenue Luxury Retailer Riflessi to Enable Sponsored Immersive 3D Digital Twins of Inventory with ADIO(R) and DVHOLO(TM)7.1.2026 13:00:00 CET | Press release
Riflessi to Deploy Digital Twins of Luxury Fashion Lines of Brunello Cucinelli, Gucci, Tom Ford, Kiton and Tommy Hilfiger® among other Leading Brands with Interactive DVHOLO 3D Holographic Display in New York's Fifth Avenue Fashion District PHILADELPHIA, PA AND NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a leader in data experience, valuation, and monetization technologies, today announced a collaboration with Riflessi, a premium Fifth Avenue retail destination in New York City frequented by global consumers and internationally-recognized fashion and lifestyle labels. The collaboration is designed to install Datavault AI's DVHOLO and ADIO technology in February 2026 and aims to generate new revenue by leveraging data and content through customized displays of luxury fashion while enabling sponsored immersive advertising experiences through Datavault AI's DVHOLOTM holographic display platform and ADIO® spatial aud
A New Shade of Comfort: LiberNovo Omni Debuts New Moss Green Design6.1.2026 08:10:00 CET | Press release
HONG KONG, HK / ACCESS Newswire / January 6, 2026 / LiberNovo The pioneer of dynamic ergonomic seating today announced the upcoming Moss Green variant of its flagship chair, the LiberNovo Omni , launching in Europe on January 17, 2026 (CET) . Building on the success of Midnight Black and Space Grey, Moss Green introduces a nature-inspired palette paired with a softer, upgraded fabric designed for long-hour comfort. As hybrid work becomes the norm across Europe, professionals increasingly seek seating that integrates seamlessly into home environments while supporting extended periods of task switching. Moss Green offers a warm, understated aesthetic that blends naturally into modern workspaces. The new colorway retains the LiberNovo Omni's full Dynamic Support system, providing adaptive support whether users are deeply focused, shifting between tasks, or relaxing after long sessions. A Calming Revival of Nature, Designed for Modern Work Inspired by forest moss, the Moss Green tone blend
Datavault AI and Available Infrastructure to Scale Physical Private Edge Cloud to Deliver Powerful Zero Trust Cybersecurity, Digital Twin and Agentic Data Monetization to 100 U.S. Cities in 20265.1.2026 14:07:00 CET | Press release
Partnership pairs Datavault AI's patented DataValue®, DataScore® and Information Data Exchange® (IDE®) solutions with Available Infrastructure's SanQtum™ cybersecure high performance points of presence designed to support near-real-time tokenization, data exchange, and agentic monetization that will provide Datavault AI the foundation to scale enterprise adoption of its AI while also solving for requisite regulatory compliance for its IDE® Quantum Key Encryption from SanQtum will further differentiate patented and forthcoming Datavault AI IDE deployments with Elements Exchange (RWA), NIL and American Political Exchanges set to Launch Q1 2026, that will be quantum ready 33 Top cities in US will begin with systems integration of patented Data Vault, DataScore, IDE and Available Infrastructure's SanQtum cybersecurity for private high performance computing in the Datavault AI Edge Network PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 5, 2026 / Datavault AI ("Datavault AI" or the "
Datavault AI and The Dream Bowl to Set New Benchmark in Sports Innovation with World’s First Tokenized Autograph Session, Featuring Current and Future NFL Stars - Live on ESPN+2.1.2026 19:50:00 CET | Press release
30 former NFL star players from different NFL Teams will autograph on-site up to 3,000 The Dream Bowl memorabilia items such as helmets, footballs, jerseys, and live-autographs by Notable Live. Autographed memorabilia items will be anchored by Prova & Sumerian technologies and digital twins will be tokenized with Data Vault. Digital tokens anchored to real The Dream Bowl autographed memorabilia items will be awarded [by lottery] to holders of the original Dream Bowl Meme Coin token (the "Dream Bowl Meme Coin I") and, following the distribution date of the Dream Bowl Meme Coin II tokens to certain record holders of Datavault AI securities as of January 7, 2026 (the "Dream Bowl Meme Coin II" and together with the Dream Bowl Meme Coin I, the "Dream Bowl Meme Coins"), to holders of the Dream Bowl Meme Coin II, throughout 2026 with an average of 10 winners selected every business day. Dream Bowl Meme Coins memorabilia digital tokens will be traded on Datavault AI's forthcoming International
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom